Try our beta test site
885 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Carcinoma, Bronchogenic" (885 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
3 Recruiting Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Bronchial Neoplasms;   Carcinoma, Bronchogenic;   Lung Diseases;   Lung Neoplasms
Intervention:
4 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
5 Not yet recruiting International Lung Screen Trial (ILST)
Conditions: Non-small Cell Lung Cancer;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Smokers at Risk of Lung Cancer
Intervention: Radiation: Low dose CT
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
8 Not yet recruiting Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Patient Reported Outcomes
9 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
10 Recruiting A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies
Condition: Non-Small Cell Lung Cancer
Intervention: Device: Video-Assisted Thoracoscopic Lobectomy with powered vascular stapler
11 Not yet recruiting Multicentric Retrospective Prognostic Evaluation of Tumor Volume and Their Changes in Radical Radiotherapy of Locally Advanced NSCLC
Condition: Non Small Cell Lung Cancer Stage III
Intervention: Radiation: Radiation
12 Recruiting Preliminary Evaluation of Safety and Efficacy of Patients Who Participant in [14C] AC0010 Trail and Subsequent Receiving AC0010 Treatment
Condition: Carcinoma,Non-Small-Cell Lung
Intervention: Drug: AC0010
13 Not yet recruiting A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Lorlatinib;   Drug: Crizotinib
14 Recruiting A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Pemetrexed
15 Recruiting Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR TKI Therapy
Conditions: Non-Small Cell Carcinoma of Lung, TNM Stage 4;   Non-Small Cell Lung Cancer;   EGFR Gene Mutation
Intervention:
16 Recruiting NY-ESO-1 TCR (TAEST16001)for Patients With Advanced NSCLC
Condition: Lung Cancer, Nonsmall Cell, Recurrent
Interventions: Drug: Cyclophosphamide;   Biological: Anti-NY-ESO-1 TCR transduced T cells
17 Recruiting A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Atezolizumab;   Drug: Daratumumab
18 Not yet recruiting Evaluation of a Food Intake Modification for Lung Cancer Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Antineoplastic Agents
Interventions: Other: Food Intake Modification;   Other: Habitual Food Intake
19 Not yet recruiting A Study of Durvalumab Versus Standard of Care in Advanced Non Small-Cell Lung Cancer
Condition: Non Small Cell Lung Carcinoma (NSCLC)
Interventions: Biological: Durvalumab (MEDI4736);   Drug: Paclitaxel + carboplatin;   Drug: Gemcitabine + cisplatin;   Drug: Gemcitabine + carboplatin;   Drug: Pemetrexed + cisplatin;   Drug: Pemetrexed + carboplatin
20 Not yet recruiting EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism
Conditions: Nonsmall Cell Lung Cancer;   EGFR Gene Mutation
Interventions: Drug: EGFR-TK Inhibitor;   Drug: EGFR-TKI;   Drug: EGFR-TKI and Chemotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.